184 related articles for article (PubMed ID: 12901871)
1. Tartrate-resistant acid phosphatase 5B circulates in human serum in complex with alpha2-macroglobulin and calcium.
Ylipahkala H; Halleen JM; Kaija H; Vihko P; Väänänen HK
Biochem Biophys Res Commun; 2003 Aug; 308(2):320-4. PubMed ID: 12901871
[TBL] [Abstract][Full Text] [Related]
2. Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption.
Halleen JM; Tiitinen SL; Ylipahkala H; Fagerlund KM; Väänänen HK
Clin Lab; 2006; 52(9-10):499-509. PubMed ID: 17078477
[TBL] [Abstract][Full Text] [Related]
3. Secreted tartrate-resistant acid phosphatase 5b is a Marker of osteoclast number in human osteoclast cultures and the rat ovariectomy model.
Rissanen JP; Suominen MI; Peng Z; Halleen JM
Calcif Tissue Int; 2008 Feb; 82(2):108-15. PubMed ID: 18084692
[TBL] [Abstract][Full Text] [Related]
4. Tartrate-resistant acid phosphatase 5B is a specific and sensitive marker of bone resorption.
Halleen JM
Anticancer Res; 2003; 23(2A):1027-9. PubMed ID: 12820342
[TBL] [Abstract][Full Text] [Related]
5. Serum tartrate-resistant acid phosphatase 5b, but not 5a, correlates with other markers of bone turnover and bone mineral density.
Halleen JM; Ylipahkala H; Alatalo SL; Janckila AJ; Heikkinen JE; Suominen H; Cheng S; Väänänen HK
Calcif Tissue Int; 2002 Jul; 71(1):20-5. PubMed ID: 12073156
[TBL] [Abstract][Full Text] [Related]
6. Osteoclast-derived serum tartrate-resistant acid phosphatase 5b in Albers-Schonberg disease (type II autosomal dominant osteopetrosis).
Alatalo SL; Ivaska KK; Waguespack SG; Econs MJ; Väänänen HK; Halleen JM
Clin Chem; 2004 May; 50(5):883-90. PubMed ID: 15016726
[TBL] [Abstract][Full Text] [Related]
7. Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoform 5b as a marker of bone resorption.
Hannon RA; Clowes JA; Eagleton AC; Al Hadari A; Eastell R; Blumsohn A
Bone; 2004 Jan; 34(1):187-94. PubMed ID: 14751577
[TBL] [Abstract][Full Text] [Related]
8. Development of a kinetic assay for band 5b tartrate-resistant acid phosphatase activity in serum.
Nakanishi M; Yoh K; Miura T; Ohasi T; Rai SK; Uchida K
Clin Chem; 2000 Apr; 46(4):469-73. PubMed ID: 10759470
[TBL] [Abstract][Full Text] [Related]
9. [Development for the determination of band 5b tartrate-resistant acid phosphatase activity in serum].
Uchida K; Nakanishi M; Yoh K
Rinsho Byori; 2001 Jan; 49(1):51-5. PubMed ID: 11215484
[TBL] [Abstract][Full Text] [Related]
10. Properties and expression of human tartrate-resistant acid phosphatase isoform 5a by monocyte-derived cells.
Janckila AJ; Parthasarathy RN; Parthasarathy LK; Seelan RS; Hsueh YC; Rissanen J; Alatalo SL; Halleen JM; Yam LT
J Leukoc Biol; 2005 Feb; 77(2):209-18. PubMed ID: 15542543
[TBL] [Abstract][Full Text] [Related]
11. Tartrate-resistant acid phosphatase forms complexes with alpha2-macroglobulin in serum.
Brehme CS; Roman S; Shaffer J; Wolfert R
J Bone Miner Res; 1999 Feb; 14(2):311-8. PubMed ID: 9933487
[TBL] [Abstract][Full Text] [Related]
12. A novel immunoassay for the determination of tartrate-resistant acid phosphatase 5b from rat serum.
Alatalo SL; Peng Z; Janckila AJ; Kaija H; Vihko P; Vaananen HK; Halleen JM
J Bone Miner Res; 2003 Jan; 18(1):134-9. PubMed ID: 12510815
[TBL] [Abstract][Full Text] [Related]
13. [Tartrate resistant acid phosphatase--TRACP-5b as a modern bone resorption marker].
Nowak Z; Konieczna M; Saracyn M; Wańkowicz Z
Pol Merkur Lekarski; 2008 Apr; 24(142):351-4. PubMed ID: 18634372
[TBL] [Abstract][Full Text] [Related]
14. Specificity and clinical performance of two commercial TRACP 5b immunoassays.
Ylipahkala H; Fagerlund KM; Janckila AJ; Houston B; Laurie D; Halleen JM
Clin Lab; 2009; 55(5-6):223-8. PubMed ID: 19728556
[TBL] [Abstract][Full Text] [Related]
15. Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma.
Terpos E; de la Fuente J; Szydlo R; Hatjiharissi E; Viniou N; Meletis J; Yataganas X; Goldman JM; Rahemtulla A
Int J Cancer; 2003 Sep; 106(3):455-7. PubMed ID: 12845688
[TBL] [Abstract][Full Text] [Related]
16. Tartrate-resistant acid phosphatase isoform 5b as serum marker for osteoclastic activity.
Janckila AJ; Takahashi K; Sun SZ; Yam LT
Clin Chem; 2001 Jan; 47(1):74-80. PubMed ID: 11148180
[TBL] [Abstract][Full Text] [Related]
17. High Uric Acid (UA) Negatively Affects Serum Tartrate-Resistant Acid Phosphatase 5b (TRACP 5b) Immunoassay.
Wu ZQ; Zhang Y; Xie E; Song WJ; Yang RX; Yan CJ; Zhang BF; Xu HG
PLoS One; 2016; 11(1):e0147554. PubMed ID: 26800211
[TBL] [Abstract][Full Text] [Related]
18. Altered serum levels of the osteoclast-specific TRACP 5b isoform in Chinese children undergoing orthodontic treatment.
Tang SJ; Meikle MC; MacLaine JK; Wong RW; Rabie BM
Eur J Orthod; 2013 Apr; 35(2):169-74. PubMed ID: 22467569
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the activity of tartrate-resistant acid phosphatase isoform 5b in normal Chinese children--a novel marker for bone growth.
Chen CJ; Chao TY; Janckila AJ; Cheng SN; Ku CH; Chu DM
J Pediatr Endocrinol Metab; 2005 Jan; 18(1):55-62. PubMed ID: 15679069
[TBL] [Abstract][Full Text] [Related]
20. Serum tartrate-resistant acid phosphatase isoforms in rheumatoid arthritis.
Janckila AJ; Neustadt DH; Nakasato YR; Halleen JM; Hentunen T; Yam LT
Clin Chim Acta; 2002 Jun; 320(1-2):49-58. PubMed ID: 11983200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
